• 1
    Arjomand H, Turi Z, McCormick D, et al. Percutaneous coronary intervention: historical perspectives, current status, and future direction. Am Heart J. 2003;146:787796.
  • 2
    Biondi-Zoccai GC, Agostoni P, Abbate A, et al. Adjusted indirect comparison of intracoronary drug eluting stent: evidence from a metaanalysis of randomized bare metal stent controlled trials. Int J Cardiol. 2005;100:119123.
  • 3
    Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:21262130.
  • 4
    Grines CL, Bonow RO, Casey DE Jr, et al; American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association; American College of Physicians. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007; 115(6):813818.
  • 5
    Jaffe R, Strauss BH. Late and very late thrombosis of drug eluting stents. Evolving concepts and perspectives. J Am Coll Cardiol. 2007;50(2):119127.
  • 6
    Nguyen TA, Diodati JG, Pharand C. Resistance to Clopidrogel: a review of the evidence. J Am Coll Cardiol. 2005;45(8):11571164.
  • 7
    Newsome LT, Kutcher MA, Royster RL. Coronary artery stents: part I. Evolution of percutaneous coronary intervention. Anesth Analg. 2008;107(2):552569.
  • 8
    Burger W, Chemnitius JM, Kneissl GD, et al. Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation: a review and meta-analysis. J Intern Med. 2005;257(5):399414.
  • 9
    Spahn DR, Howell SJ, Delabays A, et al. Coronary stents and perioperative anti-platelet regimen: dilemma of bleeding and stent thrombosis. Br J Anaesth. 2006;96(5):675677.
  • 10
    Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ. 2002;324(7239):7186.
  • 11
    Chu MW, Wilson SR, Novick RJ, et al. Does clopidogrel increase blood loss following coronary artery bypass surgery? Ann Thorac Surg. 2004;78(5):15361541.
  • 12
    Chen L, Bracey AW, Radovancevic R, et al. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2004;128(3):425431.
  • 13
    Shim JK, Choi YS, Oh YJ, et al. Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2007;134(1):5964.
  • 14
    Kennedy MT, Roche S, Fleming SM. The association between aspirin and blood loss in hip fracture patients. Acta Orthop Belg. 2006;72(1):2933.
  • 15
    Steinhubl SR, Berger PB, Mann JT 3rd, et al. Early and sustained dual antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288(18):24112420.
  • 16
    Yan BP, Gurvitch R, Ajani AE. Double jeopardy: balance between stent thrombosis with prolonged dual antiplatelet therapy after drug eluting stent implantation. Cardiovasc Revasc Med. 2006;7(3):155158.
  • 17
    Cutlip DE, Baim DS, Ho KK, et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation. 2001;103(15):19671971.
  • 18
    Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med. 1998;339:16651671.
  • 19
    Newsome LT, Kutcher MA, Ghandi SK, et al. A Protocol for the Perioperative Management of Patients with Intracoronary Drug-eluting Stents. APSF Newsletter, Winter 2006–07 Wake Forest Model.
  • 20
    Bertrand ME, Legrand V, Boland J, et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlodipine (fantastic) study. Circulation. 1998;98(16):15971603.
  • 21
    Ferrari E, Benhamou M, Cerboni P, et al. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol. 2005;45(3):456459.
  • 22
    Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol. 2007;49(22):21452150.
  • 23
    Lip YHG, Chin SPB, Blann DA. Cancer and the prothrombotic state. Lancet Oncol. 2002;3(1):2734.
  • 24
    Hara Y, Steiner M, Baldini MG. Characterization of the platelet aggregating activity of tumor cells. Cancer Res. 1980;40:12171222.
  • 25
    Pober JS. Warner-Lambert/Parke-Davis award lecture. Cytokine mediated activation of vascular endothelium. Am J Pathol. 1988;133(3):426433.
  • 26
    Gertz K, Laufs U, Lindauer U, et al. Withdrawal of statin abrogates stroke protection in mice. Stroke. 2003;34(2):551557.
  • 27
    Vecchione C, Brandes RP. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice. Circ Res. 2002;91(2):173179.
  • 28
    Bavry AA, Kumbhani DJ, Helton TJ. Late thrombosis of drug eluting stents: a meta-analysis of randomized clinical trials. Am J Med. 2006;119(12):10561061.
  • 29
    Moreno R, Fernandez C, Hernandez R, et al. Drug eluting stent thrombosis results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol. 2005;45(6):954959.
  • 30
    Bavry AA, Kumbhani DJ, Helton TJ. What is the risk of stent thrombosis associated with the use of Paclitaxel eluting stents for percutaneous coronary intervention? A meta analysis. J Am Coll Cardiol. 2005;45(6):941946.
  • 31
    Stone G; TAXUS RCT. Meta analysis and registries, insights and unsettled issues. Presented at American College of Cardiology Meeting; March 11–14, 2006; Atlanta GA.
  • 32
    Erbel R, Di Mario C, Bartunek J, et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomized multicentre trial. Lancet. 2007;369(9576):18691875.
  • 33
    Brilakis ES, Orford JL, Gasseas P, et al. Outcome of patients undergoing balloon angioplasty. Am J Cardiol. 2005;96(4):512514.